Page last updated: 2024-11-04

sumatriptan and Constriction, Pathological

sumatriptan has been researched along with Constriction, Pathological in 2 studies

Sumatriptan: A serotonin agonist that acts selectively at 5HT1 receptors. It is used in the treatment of MIGRAINE DISORDERS.
sumatriptan : A sulfonamide that consists of N,N-dimethyltryptamine bearing an additional (N-methylsulfamoyl)methyl substituent at position 5. Selective agonist for a vascular 5-HT1 receptor subtype (probably a member of the 5-HT1D family). Used (in the form of its succinate salt) for the acute treatment of migraine with or without aura in adults.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Son, M1
Kim, DD1
Kiwan, R1
Mayich, M1
Khaw, AV1
Yildiz, O1
CiƧek, S1
Ay, I1
DemirkiliƧ, U1
Tuncer, M1

Other Studies

2 other studies available for sumatriptan and Constriction, Pathological

ArticleYear
Pearls & Oy-sters: A Journey Through Reversible Cerebral Vasoconstriction Syndrome: Sex, Drugs, and Headaches.
    Neurology, 2021, 03-30, Volume: 96, Issue:13

    Topics: Adult; Angiography, Digital Subtraction; Cerebral Hemorrhage; Cerebrovascular Disorders; Coitus; Con

2021
Hypertension increases the contractions to sumatriptan in the human internal mammary artery.
    The Annals of thoracic surgery, 1996, Volume: 62, Issue:5

    Topics: Aged; Case-Control Studies; Constriction, Pathologic; Dose-Response Relationship, Drug; Drug Evaluat

1996